Larry Robbins's LLY Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 57,771 shares of Eli Lilly and Company (LLY) worth $69.29 M, representing 1.26% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Larry Robbins has initiated a new position in LLY, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +57,771 | New Buy | 57,771 | $1199.43 |
Larry Robbins's Eli Lilly and Company Investment FAQs
Larry Robbins first purchased Eli Lilly and Company (LLY) in Q2 2026, acquiring 57,771 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Eli Lilly and Company (LLY) for 1 quarters since Q2 2026.
Larry Robbins's largest addition to Eli Lilly and Company (LLY) was in Q2 2026, adding 57,771 shares worth $69.29 M.
According to the latest 13F filing for Q2 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 57,771 shares of Eli Lilly and Company (LLY), valued at approximately $69.29 M.
As of the Q2 2026 filing, Eli Lilly and Company (LLY) represents approximately 1.26% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Eli Lilly and Company (LLY) was 57,771 shares, as reported at the end of Q2 2026.